Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
RA Travagli, KN Browning, M Camilleri - … Reviews Gastroenterology & …, 2020 - nature.com
The classic view portrays Parkinson disease (PD) as a motor disorder resulting from loss of
substantia nigra pars compacta dopaminergic neurons. Multiple studies, however, describe …
substantia nigra pars compacta dopaminergic neurons. Multiple studies, however, describe …
Manganese-induced neurotoxicity: new insights into the triad of protein misfolding, mitochondrial impairment, and neuroinflammation
DS Harischandra, S Ghaisas, G Zenitsky… - Frontiers in …, 2019 - frontiersin.org
Occupational or environmental exposure to manganese (Mn) can lead to the development of
“Manganism,” a neurological condition showing certain motor symptoms similar to …
“Manganism,” a neurological condition showing certain motor symptoms similar to …
Amyotrophic lateral sclerosis—a model of corticofugal axonal spread
H Braak, J Brettschneider, AC Ludolph… - Nature Reviews …, 2013 - nature.com
The pathological process underlying amyotrophic lateral sclerosis (ALS) is associated with
the formation of cytoplasmic inclusions consisting mainly of phosphorylated 43-kDa …
the formation of cytoplasmic inclusions consisting mainly of phosphorylated 43-kDa …
Neuron-astrocyte interactions in Parkinson's disease
I Miyazaki, M Asanuma - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease. PD
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …
Acceleration of α-synuclein aggregation by exosomes
Exosomes are small vesicles released from cells into extracellular space. We have isolated
exosomes from neuroblastoma cells and investigated their influence on the aggregation of α …
exosomes from neuroblastoma cells and investigated their influence on the aggregation of α …
Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles
LD Bernal-Conde, R Ramos-Acevedo… - Frontiers in …, 2020 - frontiersin.org
Alpha-synuclein (α-syn) is localized in cellular organelles of most neurons, but many of its
physiological functions are only partially understood. α-syn accumulation is associated with …
physiological functions are only partially understood. α-syn accumulation is associated with …
Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity
The accumulation and propagation of misfolded α-synuclein (α-Syn) is a central feature of
Parkinson's disease and other synucleinopathies. Molecular compatibility between a fibrillar …
Parkinson's disease and other synucleinopathies. Molecular compatibility between a fibrillar …
Neurotoxic effects of heavy metal pollutants in the environment: Focusing on epigenetic mechanisms
G Yu, L Wu, Q Su, X Ji, J Zhou, S Wu, Y Tang… - Environmental Pollution, 2024 - Elsevier
The pollution of heavy metals (HMs) in the environment is a significant global environmental
issue, characterized by its extensive distribution, severe contamination, and profound …
issue, characterized by its extensive distribution, severe contamination, and profound …
Neuroprotection of coenzyme Q10 in neurodegenerative diseases
X Yang, Y Zhang, H Xu, X Luo, J Yu… - Current topics in …, 2016 - ingentaconnect.com
Coenzyme Q10 (CoQ10) is a component of electron transport chain and acts as an
antioxidant. It is also used for preventing neurodegeneration against mitochondrial …
antioxidant. It is also used for preventing neurodegeneration against mitochondrial …
Cerebrospinal fluid biomarkers for P arkinson's disease–a systematic review
AD Andersen, M Binzer, E Stenager… - Acta Neurologica …, 2017 - Wiley Online Library
Diagnosis of Parkinson's disease (PD) relies on clinical history and physical examination,
but misdiagnosis is common in early stages. Identification of biomarkers for PD may allow …
but misdiagnosis is common in early stages. Identification of biomarkers for PD may allow …